the evaluation of coagulation function and platelet function after having stopped to use anti-platelet drug or anti-coagulant drug

the evaluation of coagulation function and platelet function after having stopped to use anti-platelet drug or anti-coagulant drug - the evaluation of coagulation function and platelet function after having stopped to use anti-platelet drug or anti-coagulant drug

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017075

Enrollment

100

Registered

2015-04-13

Start date

2015-04-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the patients whom schedulled to proposed operation or emergent operation

Interventions

Sonoclot which be able to measure coagulation function and platelet function intervention period is one day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients from 15 to 89 years old, whom schedulled to proposed operation or emergent operation and stopped to use anti-platelet or anti-coagulant drug

Exclusion criteria

Exclusion criteria: examinee whom has no agreement or has declinature examiee whom doctors confirmed to stop the administration of the study

Design outcomes

Primary

Measure	Time frame
the data to obtain by Sonoclot&reg;, the correlation between the preoperative value of blood test and the postoperative that, and the validity of in-hospital standard for stopping to use anti-platelet or anti-coagulant drug	—

Countries

Japan

Contacts

Public ContactKazuhiro Nakane

Sapporo Medical University School of Medicine Hospital Division

akifujito@sapmed.ac.jp011-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026